Next-level medicine with ease.

Next-level medicine
with ease.

We are a clinical-stage biopharmaceutical company unlocking previously inaccessible biologics based on a transformative technology platform.

Company

Establishing a broad pipeline of unique product candidates.

Current Pipeline

Two innovative therapies in clinical development.

Technology

Smart biologics for a range of indications enabled by moss.

Product
Spotlight

A unique opportunity in complement
disorders: Factor H (CPV-104)

Team

Eleva’s team combines decades of scientific and industry experience. We relentlessly pursue those therapeutic opportunities, where our technology and expertise can make a key difference and deliver next-level medicines to patients.

  • Stefanie Ruzzoli
    People Operations Manager
  • Danielle Püschel
    Chief Accounting Officer
  • Dr. Andreas Schaaf, Ph.D.
    Chief Scientific Officer & Managing Director
  • Dr. Holger Niederkrüger
    Technical Alliance Manager
Partner
Spotlight

Our mission is to establish a broad pipeline of unique product candidates that benefit from our moss-based technology and expertise.

News

Eleva will be at the forefront of unlocking unique biological therapies across several indications. Stay up to date on our progress to learn more about how Eleva can change patient’s lives and help forge clearly differentiated therapies.

  • May 28, 2025

    Webinar Five 
    ...focuses on Age-related Macular Degeneration (AMD), a chronic retinal disease that primarily affects older adults and represents one of the leading causes of vision loss in aging populations.
News

Stay in the loop and subscribe Eleva’s newsletter

Career

Eleva offers a workplace that is focused on a valuable goal – bringing unique therapies to patients in need.

Next Page

Company